FDA Gives Thumbs Up to Ovarian Cancer Drug Lynparza (Olaparib) In a clinical trial, AstraZeneca's Lynparza shrank and even removed ovarian tumor in women whose ovarian cancer is linked with genetic mutations. by Rhodi Lee